Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial
Table 4
Secondary outcomes. Values are presented as n (%) or mean ± standard deviation.
Variable
Group
PENG (n = 25)
Control (n = 25)
Time to first opioid demand
0–3 h postoperatively
0 (0.0)
6 (24.0)
<0.0011
3–6 h postoperatively
0 (0.0)
8 (32.0)
6–9 h postoperatively
3 (12.0)
10 (40.0)
9–12 h postoperatively
5 (20.0)
1 (4.0)
>12 h postoperatively
17 (68.0)
0 (0.0)
Quadriceps muscle strength
Before block
0 = intact
20 (80.0)
15 (60.0)
0.1131
1 = reduced
5 (20.0)
6 (24.0)
2 = absent
0 (0.0)
4 (16.0)
3 = uncheckable
At 6 h postoperatively
0 = intact
16 (64.0)
14 (56.0)
0.2621
1 = reduced
7 (28.0)
6 (24.0)
2 = absent
2 (8.0)
1 (4.0)
3 = uncheckable
0 (0.0)
4 (16.0)
At 12 h postoperatively
0 = intact
18 (72.0)
15 (60.0)
0.1801
1 = reduced
7 (28.0)
6 (24.0)
2 = absent
0 (0.0)
4 (16.0)
3 = uncheckable
At 24 h postoperatively
0 = intact
20 (80.0)
15 (60.0)
0.1131
1 = reduced
5 (20.0)
6 (24.0)
2 = absent
0 (0.0)
4 (16.0)
3 = uncheckable
Postoperative complications
Delirium
0 (0.0)
2 (8.0)
0.4901
Respiratory depression (hypoxia, hypopnea)
0 (0.0)
0 (0.0)
Hypotension
0 (0.0)
1 (4.0)
1.0001
Nausea
1 (4.0)
1 (4.0)
1.0001
Vomiting
1 (4.0)
1 (4.0)
1.0001
Headache
1 (4.0)
2 (8.0)
1.0001
Dizziness
1 (4.0)
4 (16.0)
0.3491
Patient satisfaction
Satisfied
22 (88.0)
13 (52.0)
0.0052
Unsatisfied
3 (12.0)
12 (48.0)
1 values were derived from Fisher’s exact test. 2 values were derived using the chi-squared test. PENG, pericapsular nerve group; control, control group.